According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.94. In 2022 the company made an earnings per share (EPS) of -$1.04 a decrease over its 2021 EPS that were of $2.38.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.95 | -7.91% |
2022 | -$1.04 | -143.5% |
2021 | $2.38 | -226.43% |
2020 | -$1.88 | -11.39% |
2019 | -$2.13 | -25.47% |
2018 | -$2.85 | -23.94% |
2017 | -$3.75 | 143.74% |
2016 | -$1.54 |